Savara

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.

About SVRA

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis. 

CEO
Matthew Pauls
CEOMatthew Pauls
Employees
59
Employees59
Headquarters
Langhorne, Pennsylvania
HeadquartersLanghorne, Pennsylvania
Founded
1995
Founded1995
Employees
59
Employees59

SVRA Key Statistics

Market cap
394.07M
Market cap394.07M
Price-Earnings ratio
-4.59
Price-Earnings ratio-4.59
Dividend yield
Dividend yield
Average volume
1.79M
Average volume1.79M
High today
$2.39
High today$2.39
Low today
$2.23
Low today$2.23
Open price
$2.35
Open price$2.35
Volume
1.07M
Volume1.07M
52 Week high
$5.11
52 Week high$5.11
52 Week low
$1.89
52 Week low$1.89

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
25%
Sell
0%

People also own

Based on the portfolios of people who own SVRA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.